Cimpress plc (Nasdaq: CMPR) invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization is a competitive strategy which seeks to produce goods and services to meet individual customer needs with near mass production efficiency.
39 Reviews
As of writing this review, the company is fully WFH with no signs of going hybrid or fully RTO. Engineers are smart and helpful. Salary is decent, but WLB and career growth is dependent on the team and tasks you're doing. Great place to start as a new grad.
Management seems to be confused on the direction of the company. Tech debt is piling up, and the stuff you're working on will probably not bring any profit, if they were even used. Salary is good for entry-level but stagnates on seniority. Career growth also slows down.
Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.
Global Personalized Gifts and Cards Market report emphasizes the detailed understanding of some decisive factors such as size share sales forecast trends supply production demands industry and CAGR in order to provide a comprehensive outlook of the global market Additionally ...